Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities

Posted on by Alexis
R Ryanne Wu, Rachel A Myers, Joan Neuner, Catherine McCarty, Irina V Haller, Melissa Harry, Kimberly G Fulda, David Dimmock, Tejinder Rakhra-Burris, Adam Buchanan, Geoffrey S Ginsburg, Lori A Orlando
Background: Systematically assessing disease risk can improve population health by identifying those eligible for enhanced prevention/screening strategies. This study aims to determine the clinical impact of a systematic risk assessment in diverse primary care populations.
Keywords: Clinical decision support; Family health history; Health belief model; Hybrid implementation-effectiveness; Precision medicine; Risk assessment.

Increasing Use and Impact of Family Health History in Medically Underserved Populations

Monday, November 14 | 2-3:30 pm ET | Virtual

Family health history is a risk factor for many common chronic diseases, such as cancer and heart disease. Knowing a patient’s family health history can aid in earlier diagnoses of genetic conditions, refine disease risk assessments, inform timing and type of preventive interventions, and motivate behavior change. Despite years of public health work promoting its use, family health history remains underutilized in clinical care, especially among medically underserved populations. This webinar will focus on challenges, needs, and approaches to increasing the use and impact of family health history in medically underserved populations, both nationally and globally.

Registration is required. Sign up on the event website.

Speakers:

Nadeem Qureshi, MD
Clinical Professor, Faculty of Medicine & Health Sciences
School of Medicine
University of Nottingham Medical School

Kimberly A. Kaphingst, ScD
Professor, Department of Communication
Director of Cancer Communication Research, Huntsman Cancer Institute
University of Utah

Moderator: Grant Wood, Independent Advisor on Clinical Genomics Technology

 

Coronary Heart Disease, Family History and Public Health: From Familial Hypercholesterolemia to Elevated Lipoprotein A

Thursday, April 27 | 11 am-12 p.m. ET | Online
CDC Webinar: Coronary Heart Disease, Family History and Public Health: From Familial Hypercholesterolemia to Elevated Lipoprotein A

Heart disease remains the number one cause of death in the United States and around the world. In addition to known risk factors for heart disease, family history plays an important role. In the past decade, major advances have occurred at the intersection of genomics, heart disease and public health. Familial hypercholesterolemia (FH), a genetic disorder of cholesterol metabolism affecting millions of people, has emerged as public health genomics priority for preventing premature morbidity and mortality from heart disease. In addition, elevated lipoprotein (a) (Lp(a)) increases the risk of coronary heart disease, occur in 1 in 5 people, have a strong genetic basis, and accentuate the cardiovascular risk from FH and other risk factors.

This seminar will explore advances in FH and Lp(a) and the emerging clinical and public health approaches to reducing the burden of cardiovascular disease using genetics and family history.

Please note: registration is required. Visit the CDC’s website to learn more and sign up.

Laurence Sperling, MD, FACC, FACP, FAHA, FASPC; Ijeoma Isiadinso MD, MPH, FACC, FASNC